Refreshing results…
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial
UploadTisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma
UploadCharacteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation
UploadMissing publications? Search for publications with a matching author name.